Windward Bio
Windward Bio is a clinical-stage drug development company focused on improving outcomes for individuals with advanced immunological diseases, particularly severe respiratory conditions. The company is advancing a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP) into phase 2 development while creating innovative bispecific programs for various immunological disorders. Led by a team of biopharmaceutical executives, Windward Bio aims to address significant unmet medical needs in this field.
Domain
windwardbio.com
Country
SwitzerlandIndustry
BiotechnologyEmployees
11-50
Last Funding
$200.0M
Founded
2023
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Windward Bio use?+
Windward Bio uses 19 technologies including Elementor, Google Analytics, Google Tag Manager.
What industry is Windward Bio in?+
Windward Bio operates in the Biotechnology industry.
Where is Windward Bio based?+
Windward Bio is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026